Looked into Condella's background in Pharma companies he's experienced alright Teva's a good example of what can happen with him around and he's our Chair so help us .
- Forums
- ASX - By Stock
- MYX
- Ann: Mayne Pharma to restate US dermatology net revenue for FY22
MYX
mayne pharma group limited
Add to My Watchlist
0.00%
!
$5.07

Ann: Mayne Pharma to restate US dermatology net revenue for FY22, page-22
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.07 |
Change
0.000(0.00%) |
Mkt cap ! $409.4M |
Open | High | Low | Value | Volume |
$5.05 | $5.08 | $5.02 | $336.5K | 66.66K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2762 | $5.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.07 | 2771 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 158 | 5.060 |
4 | 2945 | 5.050 |
5 | 24561 | 5.040 |
2 | 1123 | 5.030 |
3 | 1318 | 5.020 |
Price($) | Vol. | No. |
---|---|---|
5.070 | 1521 | 7 |
5.080 | 3429 | 4 |
5.090 | 1505 | 6 |
5.100 | 26181 | 5 |
5.110 | 973 | 2 |
Last trade - 15.25pm 07/08/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |